Press
RCOphth President responds to HSIB report on lack of timely monitoring for patients with glaucoma
The Royal College of Ophthalmologists would like to thank the patient who was willing to participate in important investigations, such as this report carried out by the Healthcare Safety Investigation Branch (HSIB) despite the devastating impact on her quality of life as a result of her sight loss. The hospital investigated is not identified in
National Ophthalmology Database receives funding boost
The Royal College of Ophthalmologists is delighted to announce that the National Ophthalmology Database Audit (NOD) has received further funding for 2020. The contribution provided by Bausch + Lomb for the calendar year of 2020, will help ensure the continued aims of the audit to facilitate the highest standards of quality assurance and improvement in patient care
RCOphth Manifesto 2019: Workforce revitalisation, smart data and new ways of working
The next government must put the workforce at the heart of its vision for healthcare if it is to create a sustainable eyecare service that meets the needs of patients and staff, says The Royal College of Ophthalmologists (RCOphth) in its general election manifesto, published today. RCOphth calls on the next government to ensure that the
The Ulverscroft David Owen Award 2020 opens for applications
The Royal College of Ophthalmologists is delighted to open the second Ulverscroft David Owen Award. In memory of David Owen who chaired the Ulverscroft Foundation, the College and the Foundation are offering £500 prize in recognition of high-quality research in paediatric ophthalmology. Last year’s award went to Lola Solebo for her study into IOL implants
Prestigious £100,000 IGA and RCOphth research grant launched
There are 700,000 people in the UK living with glaucoma, an eye disease that without treatment typically causes loss of vision. Over the next ten years, glaucoma cases are predicted to rise by 22% and over 20 years by 44%. Research is vital to improve understanding of glaucoma and develop innovative and sight-saving treatments. The